Abstract:Objective To investigate the clinical risk factors related to the cirrhosis development in patients with hepatitis B virus infection. Methods A total of 988 participants with hepatitis B virus infection were collected for this study in Zhong Shan Hospital affiliated with Fu Dan University between January 2009 and January 2011. All of them were Chinese Han nationality from Shanghai and its surrounding area. Their information, including hepatitis history, serum test, liver imaging, and liver histology if available, were collected. They were divided into healthy recovered and chronic hepatitis group, the later was subdivided into cirrhotic group and non-cirrhotic group. The general informations and clinical determination datas were compared with statistical analysis by using SPSS 18.0 and STATA 11.0 software. Results (1) The ratio of male/female participants was 736/252, and the average age was 50.8±13.2. The numbers of participants in healthy recovered group, non-cirrhotic chronic hepatitis and cirrhotic group were 274, 285, and 429, respectively, and the average ages were 56.7±13.6, 49.2±11.5, and 47.5±13.5, respectively. Chronic hopatitis B (CHB) familial history was found in 2.2% participants of the healthy recovered group and 47.5% participants of chronic hepatitis group. The vertical infection rates were 56.3% in healthy recovered group, and 93.7% in chronic hepatitis group, which have significant difference between them. For chronic hepatitis group, the vertical rates of non-cirrhotic and cirrhotic group were 89.4% and 96.4%, respectively, which also have significant difference between them. The vertical infection was a risk factor for chronicity of hepatitis B (OR=15.02, 95% CI:9.57-23.94) and the development of cirrhosis (OR=3.15, 95%CI:1.39-7.45). The duration of disease of cirrhotic patients (44.1±9.5 years) was longer than that of non-cirrhotic CHB patients (39.3±9.8 years). The ratio of male patients in cirrhotic group was also significantly higher than that in non-cirrhotic group (70.2%) and the duration of disease for male patients (41.7±9.3 years) were shorter than that of female patients (45.0±11.4 years).(2) The levels of liver function rests were significantly different among healthy recover, non-cirrhotic, and cirrhotic group of CHB patients. There were negative correlation between HBsAg and HBV DNA in HBeAg positive patients (r=-0.43);However positive correlation in HBeAg negative patients (r=0.23) was observed. HBsAg level, which was higher than 1 000 COI, of cirrhotic patients (89.5%) was significant higher than that of non-cirrhotic patients (89.5%) (OR=1.86, 95% CI:1.18-2.94). No correlation was found betweem HBV DNA level and the duration of disease of CHB (P=0.21). Although HBV DNA level in cirrhotic group was significantly higher than that in non-cirrhotic group (2.875±2.68 log10copies/mL), the ratio of patients with HBV DNA level, which was higher than 5 log10copies/mL in cirrhotic group (31%) was significantly lower than that in non-cirrhotic group(57.2%). Conclusion The factors associated with cirrhosis development in CHB patients include duration of diseases, familial history, route of infection (vertical infection), male gender, the level of HBsAg(higher than 1 000 COI), and HBV DNA level.

The Distribution of HBV Genotypes and Clinical Significance in Familial Clustering in an Infected Population with Unfavorable Prognosis

Study on hepatitis B virus genotypes in Wenzhou district by PCR using type-specific primers and its clinical significance

Significance and Distribution of HBV Genotypes in Infected Family Members in Guangdong Province

Determination of Distribution of Hepatitis B Virus Genotype in Infected Population in Chongqing Region by Real-Time Fluorescent Genotyping and Quantitative PCR

[Distribution and Clinical Significance of Hepatitis B Virus (HBV) Genotypes and Subtypes in HBV-infected Patients].

HBV Genotype Characterization and Distribution in Patients with HBV-related Liver Diseases in Zhejiang Province, P.R. China: Possible Association of Co-Infection with Disease Prevalence and Severity.

HBV Infection and Familial Aggregation of Liver Cancer: An Analysis of Case-Control Family Study

[Clinical Characteristies and Distribution of Hepatitis B Virus Genotype and Sub-Genotype].

Risk factors for familial clustering of hepatitis C virus infection in a Chinese Han population: a cross-sectional study

Analysis of Genotype and Quantification of Hepatitis B Virus by Real-Time PCR Assay

The Association of Adverse Outcomes in the Mother with Disease Progression in Offspring in Families with Clusters of Hepatitis B Virus Infection and Unfavorable Prognoses in Northwest China

The Relationship Between the Hepatitis B Virus Genotype and Clinical Outcomes in Northern and Western Chinese Population

A Type-Specific Nested PCR Assay Established and Applied for Investigation of HBV Genotype and Subgenotype in Chinese Patients with Chronic HBV Infection.

Distribution of Hepatitis B Virus Genotype and Subgenotype and Its Clinical Significane

Evaluation of the clinical risk factors associated with liver cirrhosis in patients with chronic hepatitis B viral infection

Associations between hepatitis B virus genotype and mutants and the risk of hepatocellular carcinoma

Distribution and Clinical Correlates of Viral and Host Genotypes in Chinese Patients with Chronic Hepatitis C Virus Infection.

Distribution of Hepatitis B Virus Genotypes and Subgenotypes in Shandong Area

Association of hepatitis B virus mutations in basal core promoter and precore regions with severity of liver disease: an investigation of 793 Chinese patients with mild and severe chronic hepatitis B and acute-on-chronic liver failure

Hepatitis B Virus Genotypes, Phylogeny and Occult Infection in a Region with a High Incidence of Hepatocellular Carcinoma in China

Clinical implication and viral mutation in basal core promoter/pre-core of hepatitis B virus C/D recombinant